<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE341nnn/GSE341409/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE341409</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>RNAseq analysis of H69 cholangiocyte cell line stimulated with imidazole propionate</name><description>Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease of the bile ducts associated with inflammatory bowel disease and an altered gut microbiota. Here we studied the transcriptomic impact of the gut microbial metabolite imidazole propionate and its precursor urocanate on a human cholangiocyte cell line.</description><dates><publication>2026/08/10</publication></dates><accession>GSE341409</accession><cross_references><GSM>GSM9906224</GSM><GSM>GSM9906223</GSM><GSM>GSM9906226</GSM><GSM>GSM9906225</GSM><GSM>GSM9906220</GSM><GSM>GSM9906222</GSM><GSM>GSM9906221</GSM><GSM>GSM9906209</GSM><GSM>GSM9906228</GSM><GSM>GSM9906227</GSM><GSM>GSM9906208</GSM><GSM>GSM9906229</GSM><GSM>GSM9906213</GSM><GSM>GSM9906235</GSM><GSM>GSM9906234</GSM><GSM>GSM9906212</GSM><GSM>GSM9906237</GSM><GSM>GSM9906215</GSM><GSM>GSM9906236</GSM><GSM>GSM9906214</GSM><GSM>GSM9906231</GSM><GSM>GSM9906230</GSM><GSM>GSM9906233</GSM><GSM>GSM9906211</GSM><GSM>GSM9906210</GSM><GSM>GSM9906232</GSM><GSM>GSM9906217</GSM><GSM>GSM9906216</GSM><GSM>GSM9906219</GSM><GSM>GSM9906218</GSM><GPL>34281</GPL><GSE>341409</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>